Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
Serrão
Vasco Vieira
VV
Feio
Ana Barata
AB
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D003937:Diagnosis, Differential; D005145:Face / Q000473:pathology; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007642:Keratosis / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D011355:Prodrugs / Q000008:administration & dosage / Q000009:adverse effects*; D012004:Rectal Neoplasms / Q000188:drug therapy; D012535:Scalp / Q000473:pathology
D000964:Antimetabolites, Antineoplastic; D011355:Prodrugs; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil